Company Description
Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally.
The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries.
This segment also provides testing and laboratory services to the dental and pharmaceutical industries.
The Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research.
The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides.
The Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments.
This segment’s products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems, offered under DialyGuard, ViewPoint, DataTrace, DryCal, and BGI brands.
The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.
| Country | United States |
| Founded | 1982 |
| Industry | Scientific & Technical Instruments |
| Sector | Technology |
| Employees | 736 |
| CEO | Gary M. Owens |
Contact Details
Address: 12100 W 6th Ave Lakewood, Colorado 80228 United States | |
| Phone | (303) 987-8000 |
| Website | mesalabs.com |
Stock Details
| Ticker Symbol | MLAB |
| Exchange | NASDAQ |
| Fiscal Year | April - March |
| Reporting Currency | USD |
| CIK Code | 0000724004 |
| CUSIP Number | 59064R109 |
| ISIN Number | US59064R1095 |
| Employer ID | 84-0872291 |
| SIC Code | 3823 |
Key Executives
| Name | Position |
|---|---|
| Gary M. Owens | Chief Executive Officer, President and Director |
| John V. Sakys | Vice President, Chief Financial Officer and Chief Accounting Officer |
| Brian David Archbold | Senior Vice President of Continuous Improvement |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 19, 2024 | DEF 14A | Other definitive proxy statements |
| Jun 28, 2024 | 10-K | Annual Report |
| Jun 14, 2024 | NT 10-K | Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 |
| Jun 5, 2024 | 8-K | Current Report |
| Apr 8, 2024 | 8-K | Current Report |
| Apr 2, 2024 | UPLOAD | Filing |
| Apr 2, 2024 | 8-K | Current Report |
| Mar 20, 2024 | UPLOAD | Filing |
| Mar 6, 2024 | UPLOAD | Filing |
| Feb 13, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |